Global Autoimmune Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313356
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genentech Inc.
  • MORE
Autoimmune Diseases Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022, the autoimmune diseases treatment market was valued at USD 40,944.9 Mn in 2015, and is expected to reach USD 52,456.3 Mn by 2022, expanding at a CAGR of 3.53% from 2016 to 2022.

Market Insights
According to American Autoimmune Related Diseases Association (AARDA), autoimmune diseases are caused by functional turbulence caused to immune system. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. Autoimmune disease is one of the top 10 leading causes of death in girls and women in all age groups up to 64 years of age. A close genetic relationship exists among autoimmune disease, explaining clustering in individuals and families as well as a common pathway of disease. The currently available treatment comprises chemical-based drugs such as immunosuppressant, corticosteroids and NSAIDs. Biological drugs are considered as the most developing segment of autoimmune diseases treatment market due to target-specific activity, less side-effects and high patient compliance compared to chemical- based drugs. The key factors assisting the growth of autoimmune diseases treatment market are growing prevalence of autoimmune diseases coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of laboratories leading to diagnosis of several autoimmune diseases swiftly. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market growth of autoimmune diseases treatment.
Pipeline Analysis
Pipeline of autoimmune diseases is dense and comprises of combination of chemical-based and biological drugs. However, the no. of biological molecules is more in the phase III of clinical trials compared to chemical-based drugs. There are more than 80 types of clinically different autoimmune diseases. Some of the common types of autoimmune diseases are Hashimoto's thyroiditis, type I diabetes, Crohn's disease, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis systemic lupus erythematosus, and psoriasis. We have estimated sales of very specific molecules based on the type (chemical-based or biological), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.

Key Market Movements
  • Rising prevalence of autoimmune diseases in developed and developing countries
  • Age plays crucial role in autoimmune diseases and aging population in developed countries is expected to boost the market
  • High public awareness is assisting the autoimmune disease diagnostics market and ultimately the treatment market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genentech Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Autoimmune Diseases Treatment Market Portaiture
2.2 Global Autoimmune Diseases Treatment Treament Market, by Drugs, 2015 (USD Mn)
2.3 Relativity Analysis: Global Autoimmune Diseases Treatment Market, by Geography, 2015 & 2022 (USD Mn)

Chapter 3 Autoimmune Diseases Treatment: Market Dynamics and Outlook
3.1 Autoimmune Diseases Treatment Market Overview
3.1.1 Type of Autoimmune Diseases
3.1.2 Autoimmune Disease Diagnostics
3.1.3 Autoimmune Diseases Treatment: Upcoming Trends and Techniques
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Challenges
3.3.3 Opportunities
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis: Global Autoimmune Diseases Treatment Market, 2015 (Value %)

Chapter 4 Global Autoimmune Diseases Treatment Market, by Type of Threapeutic
4.1 Preface
4.2 Chemical-Based Drugs
4.2.1 Immunosuppressant Drugs
4.2.2 Nsaids
4.2.3 Corticosteroids
4.3 Biological Drugs
4.4 Pipeline Analysis
4.4.1 Projected Sales of Phase III Drugs Estimated Till 2022, by Most Prevalent Autoimmune Diseases (US$ Mn)
4.4.1.1 Hashimoto's Thyroiditis
4.4.1.2 Type I Diabetes
4.4.1.3 Crohn's Disease
4.4.1.4 Multiple Sclerosis
4.4.1.5 Rheumatoid Arthritis
4.4.1.5 Ankylosing Spondylitis
4.4.1.5 Systemic Lupus Erythematosus
4.4.1.5 Psoriasis
4.4.2 Tabular Representation of Phase II and I Drugs

Chapter 5 Global Autoimmune Diseases Treatment Market, by Geography
5.1 Preface
5.2 North America
5.2.1 U.S
5.2.2 Canada
5.3 Europe
5.3.1 U.K
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia Pacific
5.4.1 China
5.4.2 Japan
5.4.3 Rest of Asia Pacific
5.5 Rest of the World (Row)
5.5.1 Latin America
5.5.2 Middle East and Africa

Chapter 6 Company Profiles
6.1 Genentech Inc
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Portfolio
6.1.4 News Coverage
6.2 Bayer Ag
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Portfolio
6.2.4 News Coverage
6.3 Merck & Co
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Portfolio
6.3.4 News Coverage
6.4 Amgen Inc
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Portfolio
6.4.4 News Coverage
6.5 Johnson & Johnson Limited
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Portfolio
6.5.4 News Coverage
6.6 Abbott Laboratories
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Portfolio
6.6.4 News Coverage
6.7 Eli Lilly and Company
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Portfolio
6.7.4 News Coverage
6.8 Glaxosmithkline Plc
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Portfolio
6.8.4 News Coverage
6.9 F. Hoffmann-La Roche Ag
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Portfolio
6.9.4 News Coverage
6.10 Bristol Myers Squibb Company
6.10.1 Business Description
6.10.2 Financial Health and Budget Allocation
6.10.3 Product Portfolio
6.10.4 News Coverage

List of Figures
Figure 1 Global Autoimmune Diseases Treatment Market, by Type of Therapeutics, 2015 (USD Mn)
Figure 2 Relativity Analysis: Global Autoimmune Diseases Treatment Market, by Geography, 2015 & 2022 (USD Mn)
Figure 3 Attractive Investment Proposition, Global Autoimmune Diseases Treatment Market, 2015
Figure 4 Market Share Analysis: Global Autoimmune Diseases Treatment Market, 2015 (Value %)
Figure 5 Global Chemical-Based Drugs Market for Autoimmune Diseases Treatment, 2013 - 2022 (USD Mn)
Figure 6 Global Biological Drugs Market for Autoimmune Diseases Treatment, 2013- 2022 (USD Mn)
Figure 7 Pipeline Analysis: Global Hashimoto's Thyroiditis Market for Autoimmune Diseases Treatment, Upto 2022 (USD Mn)
Figure 8 Pipeline Analysis: Global Type I Diabetes Market for Autoimmune Diseases Treatment, Upto 2022 (USD Mn)
Figure 9 Pipeline Analysis: Global Crohn's Disease Market for Autoimmune Diseases Treatment, Upto 2022 (USD Mn)
Figure 10 Pipeline Analysis: Global Multiple Sclerosis Market for Autoimmune Diseases Treatment, Upto 2022 (USD Mn)
Figure 11 Pipeline Analysis: Global Rheumatoid Arthritis Market for Autoimmune Diseases, Upto 2022 (USD Mn)
Figure 12 Pipeline Analysis: Global Ankylosing Spondylitis Market for Autoimmune Diseases, Upto 2022 (USD Mn)
Figure 13 Pipeline Analysis: Global Systemic Lupus Erythematosus Market for Autoimmune Diseases, Upto 2022 (USD Mn)
Figure 14 Pipeline Analysis: Global Psoriasis Market for Autoimmune Diseases, Upto 2022 (USD Mn)
Figure 15 Global U.S. Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 16 Global Canada Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 17 Global U.K Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 18 Global Germany Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 19 Global Rest of Europe Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 20 Global China Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 21 Global Japan Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 22 Global Rest of Asia Pacific Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 23 Global Latin America Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 24 Global Middle East and Africa Autoimmune Diseases Treatment Market Revenue, 2013 - 2022 (USD Mn)

List of Tables
Table 1 Global Autoimmune Diseases Treatment Market Revenue, by Type of Therapeutics, 2013 - 2022 (USD Mn)
Table 2 Global Autoimmune Diseases Treatment Market Revenue, by Geography, 2013 - 2022 (USD Mn)
Table 3 North America Autoimmune Diseases Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 4 Europe Autoimmune Diseases Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 5 Asia - Pacific Autoimmune Diseases Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 6 Rest of the World Autoimmune Diseases Treatment Market Revenue, by Region, 2013 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Genentech Inc.
  • Bayer AG
  • Merck & Co.
  • Amgen Inc.
  • Johnson & Johnson Limited
  • Abbott Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche AG
  • Bristol Myers Squibb Company.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll